The Expanding Remote Monitoring Access Act (HB3032) would require Medicare to pay for remote monitoring services when there are at least 2 days of data collected in a 30-day period, regardless of COVID-19 status. The bill argues that the current 16-day minimum is not always medically necessary and can hinder care.
It also directs CMS to study and report back to Congress within one year with recommendations on implementing differential reimbursement based on patient acuity and cost, and on appropriate supervision and place of service for remote monitoring data review.
At a Glance
What It Does
Mandates a 2-day minimum data collection period per 30 days for remote monitoring services payable under Medicare, effective from enactment to two years after enactment.
Who It Affects
Medicare beneficiaries receiving remote monitoring, clinicians who provide such services, and providers that run remote monitoring programs (hospitals, clinics, post-acute facilities, and professional practices).
Why It Matters
Creates broader access to remote monitoring by relaxing the data-duration rule, tests new reimbursement models, and prompts systematic evaluation of cost savings from earlier interventions.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill targets the way Medicare pays for remote monitoring practices. Currently, billing rules effectively require 16 days of monitored data within any 30-day period, which the bill asserts is not always medically necessary.
HB3032 would set a new floor: at least 2 days of data collection per 30 days must be payable, and this applies regardless of whether the patient has COVID-19. The policy is limited to a two-year window after enactment, after which CMS would need to revisit the framework.
In parallel, CMS would conduct a formal review within 12 months of enactment to assess historical pay practices, explore differential reimbursement by patient acuity and cost of care, and analyze where non-clinical staff should supervise or escalate data. The bill also defines remote monitoring as both remote physiologic monitoring and remote therapeutic monitoring and lists broad stakeholder groups to participate in the CMS study, including VA, physicians, hospitals, professional organizations, and payers.
Overall, the measure aims to expand access and encourage more flexible, data-driven care while prompting a structured evaluation of costs and care outcomes.
The Five Things You Need to Know
The bill requires Medicare to pay for remote monitoring data collection on a minimum of 2 days per 30-day period.
The 2-day minimum applies regardless of whether the patient has COVID-19.
CMS must produce a Congress-facing report within 1 year analyzing prior payer experience and recommending a differential reimbursement model by patient acuity and cost.
Remote monitoring is defined to include both remote physiologic monitoring and remote therapeutic monitoring.
The Secretary must coordinate with a broad set of stakeholders (including VA, physicians, hospitals, professional organizations, and payers) in crafting the upcoming reimbursement framework.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
This Act may be cited as the Expanding Remote Monitoring Access Act. The naming ensures a clear, consistent reference for subsequent regulatory and budget discussions.
Findings
The bill lays out evidence and rationale for revising the 16-day minimum duration to something more clinically flexible. It cites Veterans Affairs data showing benefits of remote monitoring and catalogues clinical scenarios where fewer than 16 days can still provide meaningful care. The findings underscore a gap between CMS’s historic rule and practical care needs across conditions and settings.
Ensuring Access and Reporting
Section 3(a) requires the Secretary to ensure that Medicare payments for remote monitoring remain available for at least 2 days of data collection in a 30-day period for the period from enactment to two years after enactment, without COVID-19 gating conditions. Section 3(b) obligates a report within 1 year to Congress, including analyses of prior experience, a plan for potential differential reimbursements by patient acuity and cost, and guidance on appropriate place of service and supervision for data review. Section 3(c) provides definitions and clarifications used throughout the text.
Definitions
The bill defines Remote Monitoring as comprising remote physiologic monitoring and remote therapeutic monitoring. It further clarifies what constitutes data collection and how such data supports a patient’s treatment plan, emphasizing non-face-to-face data handling and analysis used in care decisions.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Medicare beneficiaries with chronic or episodic conditions who can be managed through at-home monitoring without a lengthy data collection requirement.
- Clinicians and care teams who rely on timely remote data to adjust therapies and avoid hospitalizations.
- Hospitals, health systems, and post-acute care facilities that operate remote monitoring programs and seek consistent reimbursement.
- Remote monitoring vendors and service providers offering devices and platforms that enable data collection and review.
- Veterans Affairs and other public health systems that already integrate remote monitoring into care pathways.
Who Bears the Cost
- The Medicare program will bear higher short-term outlays to cover a broader data collection regime.
- Provider organizations may incur upfront costs to ensure data capture meets the new 2-day minimum (e.g., IT infrastructure, data review staffing).
- Non-clinical staff who review and escalate remote data may face new supervision and workflow requirements.
- States and local health systems that adopt CMS-aligned remote monitoring practices could see changes in billing and compliance costs.
Key Issues
The Core Tension
Balancing broader access to remote monitoring with the need to control costs and ensure clinically meaningful data; the bill relaxes data duration while proposing a study to justify differential reimbursements based on acuity and cost, which could create implementation complexity and variation in care.
The shift to a 2-day minimum reduces the data burden for many patients and could expand access, but it raises questions about ensuring data sufficiency for clinical decisions and the potential for cost growth in Medicare. Implementing the CMS study and potential differential reimbursements will require significant coordination across agencies, payers, and care settings, and it may introduce complexity in how services are billed and supervised.
The two-year window ensures a test period but leaves unresolved questions about long-term policy alignment, equity across patient groups, and safeguards against misuse.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.